Crown Castle vs Healthpeak Properties
Side-by-side comparison of AI visibility scores, market position, and capabilities
Houston US tower REIT (NYSE: CCI) ~$7B revenue; 40,000 towers, new CEO Christian Hillabrant (Sept 2025, ex-Vantage Towers), fiber small cells divested to EQT, 5G amendment revenue competing with American Tower.
About
Crown Castle Inc. is a Houston, Texas-based wireless communications infrastructure company — publicly traded on the New York Stock Exchange (NYSE: CCI) as an S&P 500 Real Estate component and the largest US tower REIT — owning, operating, and leasing approximately 40,000 cell towers and 85,000+ route miles of fiber and small cells that form the distributed infrastructure backbone for US wireless carriers' (AT&T, T-Mobile, Verizon) network coverage and capacity. A defining leadership and strategic transition occurred in 2025: Crown Castle appointed Christian Hillabrant as President and CEO effective September 15, 2025 — bringing 30+ years of telecom experience including CEO of Vantage Towers AG (Europe's second-largest tower company), senior leadership at T-Mobile, Ericsson, and Samsung — as the company undergoes a strategic refocus back to its core tower infrastructure business. Daniel Schlanger (who served as interim CEO) transitioned to Executive Vice President and Chief Transformation Officer to oversee the completion of Crown Castle's fiber small cells divestiture, having agreed to sell the Fiber Solutions network to EQT Infrastructure (a leading infrastructure private equity firm) — exiting the small cells/fiber business that Crown Castle had invested $10+ billion in building since 2015 under intense pressure from activist investor Elliott Investment Management. Crown Castle's tower business (generating approximately $4-5 billion in site rental revenue annually) serves the three national wireless carriers under long-term lease agreements with annual rent escalators of approximately 3%.
Denver healthcare REIT (NYSE: DOC) $21B combined; Healthpeak + Physicians Realty Trust merger Mar 2024, life science labs (SF/SD/Boston) + 300+ MOBs, competing with Alexandria Real Estate and Ventas.
About
Healthpeak Properties, Inc. is a Denver, Colorado-based healthcare real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: DOC) as an S&P 500 Real Estate component — owning, operating, and developing healthcare-focused real estate including life science laboratory buildings (biopharmaceutical R&D facilities in South San Francisco, San Diego, Boston), medical office buildings (outpatient care facilities adjacent to major hospital campuses), and continuing care retirement communities through approximately 400 employees. In March 2024, Healthpeak Properties (then trading as HCP/PEAK) completed its $21 billion merger of equals with Physicians Realty Trust (DOC — medical office REIT with 300+ medical outpatient buildings in 30+ states) — adopting Physicians Realty Trust's ticker symbol "DOC" and creating a $21 billion combined healthcare REIT with 60+ million square feet of life science labs, 18+ million square feet of medical office, and the most diversified healthcare real estate portfolio among public healthcare REITs. CEO Scott Brinker leads the combined company's strategy of capitalizing on the structural demand drivers for healthcare real estate: life science lab demand driven by NIH funding, private biopharma venture investment, and drug approval tailwinds — and medical office demand driven by the shift of healthcare delivery from hospital inpatient settings to outpatient ambulatory care facilities that require real estate closer to patient populations. Healthpeak's life science portfolio in the three dominant biotech clusters (San Francisco Bay Area, San Diego's Torrey Pines/UTC corridor, Boston's Kendall Square/Route 128 corridor) positions it in the markets where biopharma and biotech tenants require Class A laboratory space for drug discovery and development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.